Efficacy and safety of dupilumab in adolescent patients with moderate-to-severe atopic dermatitis

被引：0
|
作者：
Cork, M. J. [1 ]
Eichenfield, L. F. [2 ,3 ]
Blauvelt, A. [4 ]
Rosmarin, D. [5 ]
Hussain, I. [6 ]
Davis, J. D. [7 ]
Li, M. [8 ]
Zhang, Q. [7 ]
Gadkari, A. [7 ]
Eckert, L. [9 ]
Kamal, M. A. [7 ]
Bansal, A. [7 ]
机构：
[1] Univ Sheffield, Sheffield, S Yorkshire, England
[2] Rady Childrens Hosp, San Diego, CA USA
[3] Univ Calif San Diego, San Diego, CA 92103 USA
[4] Oregon Med Res Ctr, Portland, OR USA
[5] Tufts Med Ctr, Boston, MA USA
[6] Vital Prospects Clin Res Inst, Tulsa, OK USA
[7] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
[8] Sanofi, Bridgewater, NJ USA
[9] Sanofi, Chilly Mazarin, France
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2019年 / 139卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
605
引用
收藏
页码：S104 / S104
页数：1
相关论文
共 50 条
  • [31] Predictive Factors of Early Response to Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis
    Ferrucci, Silvia
    Casazza, Giovanni
    Zussino, Martina
    Tavecchio, Simona
    Marzano, Angelo V.
    Tedeschi, Micol
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (20)
  • [32] Dupilumab reduces inflammatory biomarkers in pediatric patients with moderate-to-severe atopic dermatitis
    Beck, Lisa A.
    Muraro, Antonella
    Boguniewicz, Mark
    Chen, Zhen
    Zahn, Joseph
    Marco, Ainara Rodriguez
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2025, 155 (01)
  • [33] Clinically meaningful responses in moderate-to-severe atopic dermatitis patients treated with Dupilumab
    de Bruin-Weller, M.
    Eckert, L.
    Simpson, E. L.
    Cork, M. J.
    Ardeleanu, M.
    Chen, Z.
    Shumel, B.
    Rossi, A. B.
    Graham, N. M. H.
    Pirozzi, G.
    Gadkari, A.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 116 - 116
  • [34] Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis
    Fargnoli, M. C.
    Esposito, M.
    Ferrucci, S.
    Girolomoni, G.
    Offidani, A.
    Patrizi, A.
    Peris, K.
    Costanzo, A.
    Malara, G.
    Pellacani, G.
    Romanelli, M.
    Amerio, P.
    Cristaudo, A.
    Flori, M. L.
    Motolese, A.
    Betto, P.
    Patruno, C.
    Pigatto, P.
    Sirna, R.
    Stinco, G.
    Zalaudek, I.
    Bianchi, L.
    Boccaletti, V.
    Cannavo, S. P.
    Cusano, F.
    Lembo, S.
    Mozzillo, R.
    Gallo, R.
    Potenza, C.
    Rongioletti, F.
    Tiberio, R.
    Grieco, T.
    Micali, G.
    Persechino, S.
    Pettinato, M.
    Pucci, S.
    Savi, E.
    Stingeni, L.
    Romano, A.
    Argenziano, G.
    Calabrese, Giulia
    Campanati, Anna
    Caruso, Cristiano
    Chello, Camilla
    De Pasquale, Tiziana
    Di Costanzo, Luisa
    Dini, Valentina
    De Pasquale, Rocco
    Del Giglio, Micol
    Fracassi, Giovanna
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2021, 32 (05) : 507 - 513
  • [35] Efficacy and safety of dupilumab in children aged ≥ 6 months to < 6 years with moderate-to-severe atopic dermatitis
    Paller, Amy S.
    Cork, Michael J.
    Siegfried, Elaine C.
    Simpson, Eric L.
    Wollenberg, Andreas
    Gonzalez, Mercedes E.
    Sun, Yiping
    O'Malley, John T.
    Bansal, Ashish
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 12 - 12
  • [36] EFFICACY AND SAFETY OF DUPILUMAB TREATMENT UP TO 1 YEAR IN INFANTS AND PRESCHOOL CHILDREN WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Cork, Michael J.
    Paller, Amy S.
    Siegfried, Elaine C.
    Xiao, Jing
    Prescilla, Randy
    Dubost-Brama, Ariane
    Bansal, Ashish
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 53 - 53
  • [37] Efficacy and safety of dupilumab in the treatment of moderate-to-severe atopic dermatitis: a meta-analysis of randomized controlled trials
    Wu, Shuying
    Wang, Huiping
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2022, 39 (03): : 601 - 610
  • [38] Efficacy and safety of dupilumab in children aged ≥ 6 months to < 6 years with moderate-to-severe atopic dermatitis
    Paller, A. S.
    Simpson, E. L.
    Siegfried, E. C.
    Cork, M. J.
    Wollenberg, A.
    Arkwright, P. D.
    Soong, W.
    Gonzalez, M. E.
    Schneider, L. C.
    Sidbury, R.
    Lockshin, B.
    Wang, Z.
    Mannent, L. P.
    Amin, N.
    Sun, Y.
    Laws, E.
    Akinlade, B.
    Kosloski, M. P.
    Dubost-Brama, A.
    O'Malley, J. T.
    Bansal, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E173 - E173
  • [39] Efficacy and safety of dupilumab in children aged ≥6 months to <6 years with moderate-to-severe atopic dermatitis
    Paller, Amy S.
    Siegfried, Elaine C.
    Simpson, Eric L.
    Wollenberg, Andreas
    Gonzalez, Mercedes E.
    Sidbury, Robert
    Lockshin, Benjamin
    Xiao, Jing
    O'Malley, John T.
    Bansal, Ashish
    ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (06) : 561 - 561
  • [40] SAFETY AND EFFICACY OF DUPILUMAB IN ADULT PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: AN ANALYSIS OF UP TO 100 WEEKS (LIBERTY AD OLE)
    Herranz, Pedro
    de la Cueva, Pablo
    Rodriguez Marco, Ainara
    Worrell, Richard
    Shumel, Brad
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 25 - 25
12345